SCHEMBL4002525

SCHEMBL4002525

CCC(CC)(C(N)=O)c1ccc(OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.49
CA2 P00918 4/20 0.49
PARP10 Q53GL7 2/20 0.48
PARP1 P09874 1/20 0.48
PARP2 Q9UGN5 1/20 0.48
PARP4 Q9UKK3 1/20 0.48
MAPK1 P28482 2/20 0.46
HSD17B10 Q99714 2/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
ALOX15 P16050 1/20 0.46
APEX1 P27695 1/20 0.46
RECQL P46063 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 1/20 0.44
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
AOC3 Q16853 1/20 0.42
CES2 O00748 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4856143 0.80 PARP1 (0.50) PARP1LMNACES2CES1KIF11
SCHEMBL4005378 0.78 KCNN4 (0.57) MAPK1ALDH1A1MAPTHDAC3HDAC1
SCHEMBL1141842 0.78 OGG1 (0.42) CA1CA2HDAC3HDAC1HDAC2
SCHEMBL8447097 0.78 MIF (0.44) ALDH1A1LMNAMAPTHDAC3HDAC1
SCHEMBL431187 0.77 HTT (0.59) ALDH1A1LMNAMAPTHDAC1KIF11
SCHEMBL16892934 0.77 CA1 (0.55) CA1CA2PARP10PARP1PARP2
SCHEMBL10813846 0.76 CA1 (0.53) CA1CA2PARP10PARP1PARP2
SCHEMBL29756028 0.76 MAPT (0.59) CA1CA2PARP10PARP1PARP2
SCHEMBL7039303 0.76 CA1 (0.53) CA1CA2PARP10PARP1PARP2
SCHEMBL30087732 0.74 CA1 (0.52) CA1CA2PARP10PARP1PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009079593-A1 PIPERAZINYL DERIVATIVES USEFUL AS MODULATORS OF THE NEUROPEPTIDE Y2 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-06-25 WO disclosed